Statistics for ProQR Therapeutics NV (id:5489 PRQR)

Valuation metrics

Market cap

386.56M

Enterprise value

254.39M

Trailing P/E (ttm)

-10.49

Forward P/E

-7.77

PEG ratio

-7.77

Price/Sales (ttm)

21.02

Price/Book (mrq)

11.93

Enterprise Value/Revenue

13.06

Enterprise Value/EBITDA

-8.39

Overview

Shares outstanding

105.91M

Float

62.83M

Shares short

677.63K

% Held by insiders

0.14%

% Held by institutions

0.25%

Average volume (10 days)

763.90K

Average volume (90 days)

Price summary

52-Week low

1.18

52-Week high

4.62

52-Week change

60.76%

Beta

0.25

50-Day moving average

2.72

200-Day moving average

2.17

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-130.21%

Operating margin

-218.94%

Operational effectiveness

Return on assets

-14.86%

Return on equity

-67.14%

Income statement

Revenue (ttm)

0.23

Revenue per share (ttm)

0.23

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-30,317,009.00

Net income to common (ttm)

-25,373,868.00

Diluted EPS (ttm)

-0.32

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

94.75M

Total cash per share (mrq)

1.09

Total debt (mrq)

18.44M

Total Debt/Equity (mrq)

69.64

Current ratio (mrq)

233.10%

Book value per share (mrq)

0.31

Cash flow

Cash flow statement

-34,304,164.00

Levered free cash flow (LFCF)

4.71M